Global Membrane Bioreactor Market

Cell culture is a process for developing substrates for the safe production of viral vaccines. 3D cell culture is an in vitro technique wherein the cells can grow in an artificially created environment. The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The main types of 3D cell culture technologies are scaffold-based, scaffold-free, and 3D bioreactors. The 3D bioreactors are small plastic cylinder chambers designed specifically for growing cells in three dimensions. The various scaffold-based technologies include hydrogels, polymeric scaffolds, micropatterned surface microplates and the different scaffold-free technologies are hanging drop microplates, spheroid microplates, microfluidic 3d cell culture, magnetic levitation and 3D bioprinting. The technologies are applied for cancer research, stem cell research, drug discovery, and regenerative medicine that are used by research laboratories and institutes, biotechnology and pharmaceutical companies, hospitals and diagnostic centers, and other end users. The 3D cell culture technologies market research report is one of a series of new reports from The Business Research Company that provides 3D cell culture technologies market statistics, including 3D cell culture technologies industry global market size, regional shares, competitors with a 3D cell culture technologies market share, detailed 3D cell culture technologies market segments, market trends and opportunities, and any further data you may need to thrive in the 3D cell culture technologies industry. This 3D cell culture technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global 3d cell culture technologies market grew from $2.39 billion in 2022 to $2.83 billion in 2023 at a compound annual growth rate (CAGR) of 18.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The 3d cell culture technologies market is expected to grow from $5.65 billion in 2027 at a CAGR of 18.9%. The increasing requirement for organ transplantation is driving the 3D Cell Culture Technologies Market. 3D cell culture helps in forming a three-dimensional structure which further helps in mimicking the tissue or organ and therefore helps in organ transplantation. 3D cell structures are capable of tissue and organ regeneration as well as providing the provision for drug toxicology screening. For instance, according to the Organ Procurement and Transplantation network, an American non-profit organization administering the organ transplantation in the US, 41,354 organ transplantations were performed in the United States in 2021 which was an increase of 5.9% as compared to 2020 and the number exceeded 40,000 mark for the first time ever.. The possibility of contaminating the cells is restricting the 3D Cell Culture technologies market. Contamination of the cell culture refers to the presence of bacteria, moulds, yeasts, viruses, and mycoplasma that can adversely affect the cell culture. Contamination usually occurs when the cells are mishandled or due to the lack of adequate care, as a result the process of regeneration may get affected. According to a study conducted by Yale and Tuff's university, it was found that 3D cultures are more complex than 2D cell cultures and they require a more controlled cellular environment in order to mimic structures for tissue or organ transplants. Therefore, probability of cell culture contamination is relatively higher in 3D cell cultures. Implementing the latest technology is the latest trend in the 3D Cell culture market. For example, various companies have adopted one such advancement in the market for 3D cell culture, this is the use of the vivo/vitro environment. Cell expansion and interactions under 2D are not appropriate in vitro models but when compared with 3D cell culture technique, it offers a better cell culture environment. The Vitro environment enables researchers or doctors to conduct the procedure in a controlled environment outside the organism. This procedure is gaining importance as it plays a vital role in monitoring the health of patients. FDA approved Biotek's 3D cell expansion system to be used as a medical device. It also approved Biotek's Polycaprolactone (PCL) which is a biodegradable polyester material that is used in many FDA-approved implants and drug delivery devices. FDA regulates the cell culture technologies under title 21, sec 864.2240. FDA states that cell and tissue culture technologies should be labelled or mentioned as sterile, or else they would be removed from the good manufacturing practice of the quality system. Each technology unit should maintain procedures to receive, review, and evaluate complaints. These procedures should also include consistent documentation of the receipts. In May 2021, CELLINK Group, a USA-based start-up that designs and supplies technologies and services to enhance biology research, has acquired Visikol Corporation for $7.5 million. With this acquisition, CELLINK made an entrance into the contract research market. Visikol Corp., an American contract research services company that provides pharma and biotech industries with leading services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology. Major players in the 3D cell culture technologies market are Becton Dickinson, Corning Incorporation, Eppendorf, GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Lonza, HiMedia Laboratories, Agilent Technologies, PromoCell GmbH, CellGenix GmbH, InvivoGen, Greiner Bio-One, Irvine Scientific, Cell Culture Company (CCC) LLC., Sera Care Life Sciences Incorporation, American Type Culture Collection, Miltenyi Biotec, AITbiotech, ESSEN, Sigma-Aldrich, Bel-Art, MilliporeSigma, Cellgenix, Sumitomo Bakelite, EMD Millipore, AffymetrixInc., VWR International, LLC., WHEATON IndustriesInc., and Sartorius AG. North America was the largest region in the 3D cell culture technologies market in 2022. Western Europe was the second largest region in the 3D cell culture technologies market. The regions covered in the global 3D cell culture technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the 3D cell culture technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The 3D cell culture technologies market consists of sales of 3D cell culture technologies such as microfluidics, hydrogels scaffolds, scaffold-free 3D cell culture techniques, spheroids, cube, spherical droplet, stacked plate, magnetic bead, organ-on-chips and other technologies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The global 3D cell culture technologies market is segmented - 1) By Type: Scaffold-based, Scaffold-free, 3D Bioreactors 2) By End Users: Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users 3) By Scaffold-based: Hydrogels, Polymeric scaffolds, Micropatterned Surface Microplates 4) By Scaffold-free: Hanging Drop Microplates, Spheroid Microplates, Microfluidic 3D Cell Culture, Magnetic Levitations & 3D Bioprinting 5) By Application: Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine

Cell culture consumables and equipment are designed to aid scientists in growing new cells in the culture media for drug development, tissue culture, engineering, gene therapy, vaccine production, and toxicity testing. The main products in cell culture consumables and equipment are consumables and instruments. The cell culture instruments involve the various instruments that are required for cell culture in the cell culture laboratory. The various instruments used in cell culture are cell culture vessels, bioreactors, biosafety cabinets, carbon dioxide incubators, and centrifuge and consumables are media, sera, and reagents. The applications involved are vaccination, toxicity testing, cancer research, drug screening and development, recombinant products, stem cell technology, regenerative medicine, and others that are used by end-users such as industrial, biotechnology, agriculture, and others. The cell culture consumables and equipment market research report is one of a series of new reports from The Business Research Company that provides cell culture consumables and equipment market statistics, including cell culture consumables and equipment industry global market size, regional shares, competitors with a cell culture consumables and equipment market share, detailed cell culture consumables and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture consumables and equipment industry. This cell culture consumables and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global cell culture consumables and equipment market grew from $10.99 billion in 2022 to $12.12 billion in 2023 at a compound annual growth rate (CAGR) of 10.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cell culture consumables and equipment market is expected to grow from $17.98 billion in 2027 at a CAGR of 10.4%. An increase in the prevalence of chronic diseases is driving the growth of the cell culture consumables and equipment market. Chronic diseases such as cancer, diabetes, heart diseases, obesity, and hypertension are growing rapidly. A few chronic diseases are caused due to loss or damage of certain types of cells. Such diseases can be cured by replacing the destroyed cells with new ones that are produced by pluripotent stem cells, using cell culture consumables and equipment. So, with the rising incidence of chronic diseases, there is an increased need for such equipment that can produce new cells outside the natural environment, thus driving the growth of this market. For example, according to the World Health Organization, chronic disease prevalence is expected to rise by 57% by the year 2020. Contamination of cell culture is the most prominent factor restricting the growth of cell culture consumables and equipment market. Contaminated culture is the presence of non-living substances or unwanted foreign microorganisms that have undesirable effects on the cell culture. Using contaminated culture cells has several negative consequences on the users and thus hampers the growth of this market. For example, an article published on MedCrave, stated that Mycoplasma is one of the most common and difficult to detect contaminants. The article also highlighted the results of a study on fibroblasts and keratinocyte cell lines that showed 32.35% of contamination, out of which 17.65% were mycoplasma contaminated cultures, followed by fungal (8.82%) and bacterial (5.88%) contaminants. Hence, the high risk associated with cell culture techniques poses a threat to the growth of the cell culture consumables and equipment market. Companies in cell culture consumables and equipment are investing more in 3D cell culture for its new and advantageous features. 3D cell culture may be defined as the culture of living cells within micro-assembled devices and supports that present a three-dimensional structure and are used to replicate a tissue or an organ in an artificial environment by allowing the cells to interact with the surroundings in all three directions. 3D cell cultures are more relevant with a higher degree of structural complexity and maintain the steady-state for more time as compared to 2D cell cultures. In August 2021, Amerigo Scientific, a US-based manufacturer of biomedical and life sciences products, launched #D cell cultures for research purposes. FDA regulates cell culture consumables and equipment in the U.S. Under title 21, Sec 864.2240. For cell and tissue culture equipment, the FDA states that if the equipment is not labelled or mentioned as sterile, it would be removed from the good manufacturing practises of the quality system. Additionally, each manufacturing unit should maintain procedures to receive, review, and evaluate complaints. These procedures require consistency and punctuality, along with the documentation of the receipts. Therefore, these regulatory standards improve the safety and efficacy of instruments and consumables used during cell culture processes. In July 2021, Sartorius, a Germany-based laboratory instrument manufacturer, acquired Xell AG for an undisclosed amount. The acquisition would expand Sartorius’ current media offering and other cell culture products. Xell AG is a Germany-based cell culture specialist. Major players in the cell culture consumables and equipment market are Becton Dickinson, Corning Incorporation, Eppendorf, GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Lonza, HiMedia Laboratories, Agilent Technologies, and PromoCell GmbH. North America was the largest region in the cell culture consumables and equipment market in 2022. Western Europe was the second largest region in the global cell culture consumables and equipment market report. The regions covered in the global cell culture consumables and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the cell culture consumables and equipment market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The cell culture consumables and equipment market consists of sales of flasks, tubes, dishes or cryovials, serological pipettes or centrifugation tubes, bottles, cell scrapers, strainers, coverslips, and inserts. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global cell culture consumables and equipment market is segmented - 1) By Product: Consumables, Instruments 2) By End User: Industrial, Biotechnology, Agriculture, Other End Users 3) By Application: Vaccination, Toxicity testing, Cancer Research, Drug Screening and Development, Recombinant Products, Stem cell technology, Regenerative Medicine, Other End Users 4) By Consumables: Media, Sera, Reagents 5) By Instruments: Cell Culture Vessels, Bioreactors, Biosafety Cabinets, Carbon Dioxide Incubators, Centrifuges

A gas separation membrane is used when there is a pressure difference between the inlet raw material and the outlet of the product, and the gases are separated according to the membrane pore size, particle diameter, and others. Ammonia plants, petrochemical industries, natural gas processing units, and others use the gas separation membrane to separate gases such as hydrogen and nitrogen in ammonia plants and hydrogen and hydrocarbon separations in petrochemical applications and many more. The main types of gas separation membrane are polyimide and polyaramide, polysulfone, cellulose acetate, and other products. The polyimide and polyaramide gas separation membranes are used for the separation of gases because of their excellent thermal, chemical, and mechanical properties as well as their extraordinary membrane-forming ability. Polyimide-based membranes for gas separation include microporous polyimide membranes, hydroxyl-functionalized polyimide, and polyimide-based carbon molecular sieve membranes. The gas separation membrane module consists of hollow fiber, spiral wound, plate and frame, and other modules. The gas separation membrane is applied in nitrogen generation and oxygen enrichment, hydrogen recovery, carbon dioxide removal, vapor/gas separation, vapor/vapor separation, air dehydration, and other applications. The gas separation membrane is used by various industries including chemical, oil and gas industry, electric power, food and beverages, and other end-users. The gas separation membrane market research report is one of a series of new reports from The Business Research Company that provides gas separation membrane market statistics, including gas separation membrane industry global market size, regional shares, competitors with a gas separation membrane market share, detailed gas separation membrane market segments, market trends and opportunities, and any further data you may need to thrive in the gas separation membrane industry. This gas separation membrane market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global gas separation membrane market size grew from $1.88 billion in 2022 to $2.09 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The gas separation membrane market size is expected to grow to $3.01 billion in 2027 at a CAGR of 9.5%. The growing demand for biogas is driving the gas separation membrane market. Biogas is a mixture of methane, carbon dioxide, and trace amounts of other gases created by the anaerobic decomposition of organic materials in an oxygen-free environment. Biogas is high in demand due to rising environmental safety issues and the demand for sustainable energy. Gas separation membranes are used in manufacturing biogas. For instance, in July 2020, according to World Biogas Association, the global trade association for biogas, by 2030, the US will produce ten times as much biogas as it is producing now. Moreover, according to the International Energy Agency, a Paris-based autonomous intergovernmental organization, about 200 million individuals, half of whom are in Africa, will abandon the conventional use of biomass through biogas by 2030. Thus, the increase in the usage of biogas will propel the demand for gas separation membranes. The development of polymeric membranes is a key trend gaining popularity in gas separation membranes. Major companies in gas separation membranes are advancing towards polymeric membranes to provide efficient gas separation. A thin, semipermeable wall between two gaseous phases is referred to as a polymeric membrane. Diverse gas separations are accomplished using polymer membranes, including the removal of carbon dioxide from natural gas, oxygen from air, hydrogen recovery, and, more recently, carbon capture. For instance, in January 2020, Toray Industries Inc., a Japan-based textile company specializing in industrial products, developed a polymeric separation membrane module. This membrane can efficiently and selectively remove hydrogen from mixtures of gases containing the molecule. This module cut the number of modules and carbon dioxide emissions from hydrogen purification operations by more than half. In June 2021, Repligen Corporation, a US-based manufacturer of biological drugs, acquired Polymem S.A. for an undisclosed amount. Through this acquisition, there is an addition of core R&D, engineering, and manufacturing knowledge in hollow fiber technology, and it increases Repligen's capacity for producing hollow fiber membranes and modules. Polymem S.A. is a France-based manufacturer of hollow fiber membranes and modules. Major players in the gas separation membrane market are Air Products and Chemicals, Inc., Air Liquide Advanced Separations, UBE Corporation, Schlumberger Limited, FUJIFILM Manufacturing Europe B.V., Parker Hannifin Corp, Membrane Technology and Research, Inc., DIC Corporation, Honeywell International Inc., Generon, Evonik Industries AG, Atlas Copco AB, Grasys JSC., Toray Industries, Inc., and GMT Membrantechnik GmbH. Asia-Pacific was the largest region in the gas separation membrane market in 2022. Asia-Pacific region is expected to be the fastest-growing region in the forecast period. The regions covered in the gas separation membrane market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the gas separation membrane market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The gas separation membrane market consists of sales of polymeric membranes, inorganic membranes, and metallic membranes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global gas separation membrane market is segmented - 1) By Product Type: Polyimide And Polyaramide, Polysulfone, Cellulose Acetate, Other Products 2) By Module: Hollow Fiber, Spiral Wound, Plate And Frame, Other Modules 3) By Application: Nitrogen Generation And Oxygen Enrichment, Hydrogen Recovery, Carbon Dioxide Removal, Vapor/Gas Separation, Vapor/Vapor Separation, Air Dehydration, Other Application 4) By End Use Industry: Chemical, Oil And Gas Industry, Electric Power, Food And Beverages, Other End Use Industry

Medical and diagnostic laboratory services are services that provide diagnostics tests for various diseases. The tests are used for detecting if the person has encountered the disease. Medical and diagnostic laboratory services makes it possible to deliver prompt, affordable, and high-quality diagnostic services in secure settings. The main types of medical and diagnostic laboratory services are diagnostic imaging centres and medical laboratory services. A diagnostic imaging center is a service provider that offers technical or comprehensive diagnostic imaging services. The different expenditure types include public and private that are used in various applications such as cardiology, oncology, neurology, orthopedics, gastroenterology, gynecology, and others. The services are used by males and females. The medical and diagnostic laboratory services market research report is one of a series of new reports from The Business Research Company that provides medical and diagnostic laboratory services market statistics, including medical and diagnostic laboratory services industry global market size, regional shares, competitors with a medical and diagnostic laboratory services market share, detailed medical and diagnostic laboratory services market segments, market trends and opportunities, and any further data you may need to thrive in the medical and diagnostic laboratory services industry. This medical and diagnostic laboratory services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical and diagnostic laboratory services market grew from $169.87 billion in 2022 to $183.84 billion in 2023 at a compound annual growth rate (CAGR) of 8.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical and diagnostic laboratory services market is expected to grow to $240.86 billion in 2027 at a CAGR of 7.0%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence rose by 57% globally, in 2020. Tests to diagnose these diseases include HbA1c tests for monitoring diabetes, biopsies, tumor marker tests, bone scans, MRI and CT scans for diagnosis of various cancers, electrocardiograms, chest X-rays, cardiac CT scans, and stress tests for detection of cardiovascular diseases. The increase in the prevalence of lifestyle diseases will increase the demand for tests to diagnose these diseases and thus will drive the medical and diagnostic laboratory services market during the forecast period. The medical and diagnostic laboratory services market is expected to limit by the rising prevalence of self-care diagnostic equipment. These tools can be used by patients without assistance from medical personnel, to diagnose particular disabilities or disorders. Common self-care diagnostic devices include glucose monitoring devices, blood pressure monitoring devices, sleep apnea monitors and temperature monitors. The ease of use of self-care devices has increased demand for them during the last decade and is expected to increase it further during the forecast period. Some virtual applications are also aiding in the diagnosis of certain health conditions. For instance, iPhone is working on an IOS accessory called Cue, which can be used as a home diagnostic kit. Self-care diagnostics is expected to have a negative impact on the traditional medical and diagnostic laboratory services market during the forecast period by reducing the need for laboratory testing for some basic tests. Medical and diagnostic laboratories are using biomarkers to measure health parameters associated with individual wellness. The health and well-being of individuals can be measured by using biomarkers to assess factors behind sleep disorders and symptoms of stress. Biomarkers such as cortisol, testosterone, and secretory IgA can indicate changes in the immune system relating to physical and mental conditions. This can be used by physicians to know the causative factors behind such conditions. This is a premium service primarily targeted at wealthy individuals and senior employees of corporations. Major companies in the medical and diagnostic laboratory services market include Laboratory Corporation of America, Eurofins, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Kaiser Permanente, RadNet, OPKO Health, Myriad Genetics, Charles River Laboratories, Inc., and NeoGenomics Laboratories, Inc. North America was the largest region in the medical and diagnostic laboratory services market in 2022. Asia-Pacific was the second largest region in the medical and diagnostic laboratory services market. The regions covered in the medical and diagnostic laboratory services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical and diagnostic laboratory services market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical and diagnostic laboratory services market includes revenues earned by entities by providing diagnostic services such as diagnostic laboratory services, X-ray, CT scan, and Mammography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical and diagnostic laboratory services market is segmented - 1) By Type: Diagnostic Imaging Centers, Medical Laboratory Services 2) By Application: Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Other Applications 3) By End User Gender: Male, Female 4) By Type of Expenditure: Public, Private Subsegments Covered: Computer Tomography (CT-Scan) Centers, Medical Radiological Laboratories, Dental or Medical X-Ray Laboratories, Ultrasound Imaging Centers, Magnetic Resonance Imaging (MRI) Centers

A single-use bioreactor is a bioreactor that has a disposable bag instead of a culture vessel. Single-use bioreactors permit processors to move to the utilization of disposable technologies, including single-use bags, in assembly steps that had been reserved for stainless steel gear. The main types of single-use bioreactors are stirred-tank SUBs, wave-induced SUBs, bubble-column SUBs, and other types. Stirred tank bioreactor designs that replicate traditionally stirred tank bioreactors have been introduced to the market, gaining more market adoption. The different types of molecules include vaccines, monoclonal antibodies, stem cells, and recombinant proteins and involve various cell types such as mammalian cells, bacteria, and yeast. The various applications involved are research and development, process development, and bioproduction. The several end-users include pharmaceutical and biopharmaceutical companies, contract research organizations (CRO), academic and research institutes, and contract manufacturing organizations (CMO). The single-use bioreactors market research report is one of a series of new reports from The Business Research Company that provides single-use bioreactors market statistics, including single-use bioreactors industry global market size, regional shares, competitors with a single-use bioreactors market share, detailed single-use bioreactors market segments, market trends and opportunities, and any further data you may need to thrive in the single-use bioreactors industry. This single-use bioreactors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global single-use bio reactors market size grew from $3.77 billion in 2022 to $4.48 billion in 2023 at a compound annual growth rate (CAGR) of 18.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The single-use bio reactors market size is expected to grow to $8.91 billion in 2027 at a CAGR of 18.8%. The rapid adoption of single-use technologies (SUTs) by the industries is expected to propel the growth of the single-use bioreactors market going forward. Single-use technology (SUT) aids biopharmaceutical manufacturers in eliminating the risk of contamination which is the greatest challenge faced by manufacturers of biopharmaceuticals and increases operational efficiency by reducing or eliminating the need for sterilization between batches. For example, according to the American Pharmaceutical Review, in 2020, single-use bioreactors are used by 71.2% of the industries in process development, and over 55% use single-use sampling systems in clinical or commercial production. Therefore, the rapid adoption of SUTs by the industry is driving the growth of the single-use bioreactor market. Product innovations are a key trend gaining popularity in the single-use bioreactors market. Innovations in technology and the increasing trend of mobile gaming technology are also encouraging market demand. Major companies in the market are focusing on launching innovative products for market growth. For instance, In March 2020, Sartorius, a Germany-based biopharmaceutical company, launched BIOSTAT STR Generation 3 with BIOBRAIN, making biopharmaceutical development and production faster, simpler, and safer. This robust industrial platform contains hardware, software, and consumables for single-use process development and commercial biomanufacturing. Biostat STR bioreactors and Flexsafe STR bags have been ranging from 12.5L to 2000L in the working volume. The system has been powered by BIOBRAIN, a new automation platform that gives biologics manufacturers the flexibility to quickly and easily configure the Biostat STR system to meet their precise needs. In April 2020, Sartorius, a Germany-based pharmaceutical and laboratory equipment supplier, acquired the life science businesses of Danaher Corporation for an undisclosed amount. This acquisition of Danaher life sciences Broadens portfolio for the development and production of biotech medicines. Danaher Corporation is a US-based company that provides single-use bioreactors. Major players in the single-use bio reactors market are CESCO Bioengineering Co. Ltd., PBS Biotech Inc., Solida Biotechnology GmbH, ABEC Inc., Eppendorf AG, Sartorius Stedim Biotech Sa Ltd., Danaher Corporation Ltd., Thermo Fisher Scientific Inc., GE Healthcare, Merck Kgaa (Merck Millipore) Pvt. Ltd., Distek Inc., Celltainer Biotech Bv Pvt.Ltd., Getinge AB, Pall Corporation, G&G Technologies Inc., SATAKE MultiMix Corporation, and Bio-Age Equipment & Service Pvt.Ltd. North America was the largest region in the single use bioreactors market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-use bioreactors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the single-use bioreactors market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The single-use bioreactors market consists of sales of stirrer single-use bioreactors and rocker single-use bioreactors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global single use bio reactors market is segmented - 1) By Type: Stirred-Tank SUBs, Wave-Induced SUBs, Bubble-Column SUBs, Other Types 2) By Molecule Type: Vaccines, Monoclonal Antibodies, Stem Cells, Recombinant Proteins 3) By Cell Type: Mammalian Cell, Bacteria, Yeast 4) By Application: Research And Development (R&D), Process Development, Bioproduction 5) By End User: Pharmaceutical And Biopharmaceutical Companies, Contract Research Organizations (CRO), Academic And Research Institutes, Contract Manufacturing Organizations (CMO)

Biorational refers to the idea that effective insect pest control can be achieved with synthetic or natural substances that are low in toxicity to nontarget creatures (such as humans, animals, and natural enemies) and the environment. Biorationals are products, such as biopesticides and non-pesticides, that can be used to manage crop stress, improve plant physiology, limit root growth, manage post-harvest, or act as an alternate control agent to conventional pesticides and antimicrobials. The main types of products in biorationals are botanicals, semiochemicals, and others. Plant-derived compounds such as pyrethrin, azadiractin, and neem oil, as well as garlic, capsaicin, and vegetable oil. Botanicals have a short life in the environment because they degrade in the presence of light and air. The different formulations include liquid, dry and are used in various crop types such as cereals and grains, fruits and vegetables, among others. The several applications include agriculture, aquaculture, structural pest control, and other applications. The biorationals market research report is one of a series of new reports from The Business Research Company that provides biorationals market statistics, including biorationals industry global market size, regional shares, competitors with a biorationals market share, detailed biorationals market segments, market trends and opportunities, and any further data you may need to thrive in the biorationals industry. This biorationals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global biorational market size grew from $3.28 billion in 2022 to $3.82 billion in 2023 at a compound annual growth rate (CAGR) of 16.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The biorational market size is expected to grow to $6.59 billion in 2027 at a CAGR of 14.6%. Increasing adoption of integrated pest management is driving the demand for biorational products going forward. Integrated Pest Management is a system of managing pests that has been designed to be sustainable. Integrated pest management involves using the best combination of cultural, biological, and chemical measures for particular circumstances, including plant biotechnology as appropriate. The use of biorational products for the management of insect pests has grown intensively, which has increased its popularity. The Government of India has adopted integrated pest management (IPM) as the main plank of plant protection in the Crop Production Programme. For instance, according to the Government of India Ministry of Agriculture and Farmers Welfare, in 2021, crop yield has been increased from 6.72–40.14% in rice and 22.7–26.63% in cotton in integrated pest management fields when compared to non-integrated pest management fields. Therefore, the increasing adoption of integrated pest management will drive the growth of the biorational market. Technological advancements have emerged as a key trend gaining popularity in the biorational market. Major companies operating in the biorationals sector are focused on introducing innovative technologies for the development of biorationals. For instance, in November 2021, Syngenta Crop Protection, a Switzerland-based company that manufactures bio-rationals, launched PLINAZOLIN technology, setting a new standard in innovative insect control. This will help growers protect their crops from a different range of pests. The launch of new technology is a result of an ongoing commitment to invest in the long-term development of innovative and effective solutions that increase crop productivity in an environmentally sustainable and responsible way. In January 2021, Rovensa, a Portugal-based agricultural company, acquired Oro Agri, Inc., for an undisclosed amount. Through this acquisition, the companies will provide customers with greater marketing, sales, and R&D support in countries already served by Rovensa business units, as well as help Rovensa create a footprint in countries not currently served by Rovensa business units. Oro Agri is a US-based company that develops and manufactures innovative biorational products. Major players in the biorational market are Isagro SpA, Summit Chemical Company, Gowan Company LLC, BASF SE, Suterra LLC, McLaughlin Gormley King, Marrone Bio Innovations, Biological Control Products, Russell IPM Ltd., Valent BioSciences LLC, and Sumitomo Chemical. North America was the largest region in the biorational market in 2022. The regions covered in the biorational market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the biorational market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The biorational market consists of sales of microbial, synthetic, and minerals. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global biorational market is segmented - 1) By Product Type: Botanicals, Semiochemicals, Other Product Types 2) By Formulation: Liquid, Dry 3) By Crop Type: Cereals and Grains, Fruits and Vegetables, Other Crop Types 4) By Application: Agriculture, Aquaculture, Structural Pest Control, Other Applications

Apheresis consumables and equipment are devices through which the blood drawn from a donor is separated into its components through plasma exchange, stem cell harvest, photopheresis, and low-density lipid removal techniques. Further, the required components like plasma or platelets are retained and the remaining is passed to the circulation. The main products of apheresis consumables and equipment are disposables and devices. The apheresis consumables are the products that are used in apheresis technology. The technologies involved in disposables and devices are centrifugation and membrane filtration and procedures involved are photopheresis, plasmapheresis, LDL apheresis, plateletpheresis, leukapheresis, erythrocytapheresis, and others. The apheresis consumables and equipment are used in applications such as renal disease, neurology, haematology, and others. The apheresis consumables and equipment market research report is one of a series of new reports from The Business Research Company that provides apheresis consumables and equipment market statistics, including apheresis consumables and equipment industry global market size, regional shares, competitors with a apheresis consumables and equipment market share, detailed apheresis consumables and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the apheresis consumables and equipment industry. This apheresis consumables and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global apheresis consumables and equipment market grew from $2.65 billion in 2022 to $2.96 billion in 2023 at a compound annual growth rate (CAGR) of 11.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The apheresis consumables and equipment market is expected to grow from $4.6 billion in 2027 at a CAGR of 11.6%. The cases of blood disorders are on the rise globally, creating a need for blood transfusions. Apheresis Equipment helps to transfuse blood for blood disorders like sickle cell anemia, leukemia, and cancer. According to a report published by Leukemia and Lymphoma Society, 60,300 people in the USA are expected to be diagnosed with leukemia, and one person is diagnosed with blood cancer every 3 minutes requiring an immediate blood transfusion. According to the American Society of Hematology, 100,000 Americans possessed sickle cell Anemia and another 2 million people carry the trait requiring Apheresis Equipment for blood transfusion. According to the International Agency for Research on Cancer (IARC), by 2040, 16.3 million new cancer cases are expected to be reported worldwide. Cancer treatment requires at least 8 units of blood per patient per procedure, thus requiring blood component collection and blood transfusion. Thus, such a high prevalence of these blood disorders increases demand for apheresis consumables and equipment. Lack of awareness about apheresis consumables and equipment restrains the apheresis consumables and equipment market. Patients in developing countries like Africa. and the Middle East are unaware of apheresis consumables and equipment and how the device can be advantageous to treating blood disorders and few lack access to the device at the medical facility due to high cost or unavailability. According to the journal of clinical apheresis, only Nigeria in the whole of West Africa. uses apheresis equipment to collect platelets. Most countries are unaware of the use of apheresis, leading to low demand for apheresis consumables and equipment, and hindering the growth of the market. Companies are developing technologically advanced and automated products that enhance the efficiency of the product (blood). Technologically advanced products like automatic apheresis equipment with continuous flow centrifugation, automated interface system, and customized anticoagulant infusion system are being developed and adopted. The adoption of automated Apheresis equipment has resulted in a more efficient and rapid blood separation process. For instance, Companies like Haemonetics Corp have developed automated apheresis equipment NexSys PCS that increases productivity and improves quality and compliance in plasma collection centres. Major players in the apheresis consumables and equipment market are Asahi Kasei Medical, Haemonetics Corporation, Kawasumi Laboratories Inc., Fresenius SE & Co. KGaA, Terumo BCT, FenwalInc., Braun Melsungen AG, TherakosInc., HemaCare Corporation, and Cerus Corporation. North America was the largest region in the apheresis consumables and equipment market in 2022. Western Europe was the second largest region in the global apheresis consumables and equipment market report. The regions covered in global apheresis consumables and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the apheresis consumables and equipment market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The apheresis consumables and equipment market consist of sales of equipment and consumables. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global apheresis consumables and equipment market is segmented - 1) By Product: Disposables, Devices 2) By Technology: Centrifugation, Membrane Filtration 3) By Application: Renal Disease, Neurology, Hematology, Other Applications 4) By Procedure: Photopheresis, Plasmapheresis, LDL Apheresis, Plateletpheresis, Leukapheresis, Erythrocytapheresis, Other Procedures

The terms "chlor-alkali" refer to the method used to manufacture chlorine and sodium hydroxide (caustic soda), both of which are basic chemicals required by industry. Chlor-alkali is a group of chemicals such as chlorine, hydrogen, and sodium hydroxide that are produced by the electrolysis of saltwater. Chlorine is abundantly produced through this process and is an essential component in bleaching agents, solvents, construction materials, and insecticides. The main types of products in chlor-alkali are chlorine-based chlor-alkali, caustic soda-based chlor-alkali, soda ash-based chlor-alkali, and others. The membrane cell process uses brine and membrane cells for chlor-alkali production with charged electrodes. The production processes include membrane cells, diaphragm cells, and others and have various applications in areas such as pulp and paper, organic chemicals, inorganic chemicals, soap and detergent, alumina, textiles, and others. The Chlor-Alkali Market Research Report is one of a series of new reports from The Business Research Company that provides chlor-alkali market statistics, including chlor-alkali industry global market size, regional shares, competitors with a chlor-alkali market share, detailed chlor-alkali market segments, market trends and opportunities, and any further data you may need to thrive in the chlor-alkali industry. This chlor-alkali market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global chlor-alkali market size grew from $74.34 billion in 2022 to $80.35 billion in 2023, at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The chlor-alkali market size is expected to grow to $103.13 billion in 2027 at a CAGR of 6.4%. The growth of the chemical industry across the globe is expected to propel the growth of the chlor-alkali market going forward. The chemical industry produces industrial chemicals and provides building blocks and raw materials for many industries, such as textiles, paint, paper, soap and detergent, pharmaceuticals, and agriculture. Chlor-alkali is used in the chemical industry to generate chemicals through an industrial process, and the growth of the chemical industry will encourage the usage of chlor-alkali to produce chlorine, hydrogen, and sodium hydroxide. For instance, according to BASF SE, a Germany-based chemicals company, global chemical production increased by 4.4% in 2021, from a negative 0.4% growth rate in 2020. Therefore, the growth of the chemical industry across the globe is driving the growth of the chlor-alkali market. Strategic partnerships and collaborations have emerged as a key trend being followed by the companies operating in the chlor-alkali market. This is owing to the presence of a large number of chlor-alkali firms operating in the industry and their desire to expand their market leadership. For instance, in June 2021, Abu Dhabi National Oil Company (ADNOC), a UAE-based oil company, and Reliance Industries Limited, an India-based integrated company across materials, entertainment, energy, retail, and digital services, formed a strategic partnership to join a new world-scale ethylene dichloride, chlor-alkali, and polyvinyl chloride production facility in Abu Dhabi. This partnership aims to leverage the strengths of both companies as global industrial leaders. Also, in October 2020, Grasim Industries Limited, an India-based manufacturing company, and Lubrizol, a US-based chemicals company, formed a partnership to manufacture chlorinated polyvinyl chloride (CPVC) resins in India. CPVC resin will be manufactured in a chlor-alkali unit at Grasim. This partnership aims to bring world-class technologies to complement Lubrizol’s growth strategy on the chlor-alkali platform in India. In April 2021, Bodal Chemicals Limited, an India-based chemical manufacturing company, acquired Mawana Sugar Limited’s chlor-alkali plant, Siel Chemical Complex (SCC), for $16.78 million. The acquisition is expected to assist the business in diversifying its current chemical product line by introducing new items. Mawana Sugar Limited is an India-based manufacturer of sugar and related products. Major players in the chlor-alkali market are AGC Inc., Tosoh Corporation, Solvay SA, The Dow Chemical Company, Tata Chemicals Ltd., Olin Corporation, Westlake Chemical Corporation, Xinjiang Zhongtai Chemical Co. Ltd., Occidental Petroleum Corporation, Hanwha Group, INOVYN ChlorVinyls Limited, Wanhua-BorsodChem, Formosa Plastics Corporation, Tronox Holdings plc, Bayer AG, and Axiall Corporation. Asia-Pacific was the largest region in the chlor-alkali market in 2022. North America was the second-largest region in the chlor-alkali market. The regions covered in the chlor-alkali market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the chlor-alkali market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The chlor-alkali market consists of sales of chlor-alkali products, including hydrogen peroxide and sodium hypochlorite. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global chlor-alkali market is segmented - 1) By Product: Chlorine-Based Chlor Alkali, Caustic Soda-Based Chlor Alkali, Soda Ash-Based Chlor Alkali, Other Products 2) By Production Process: Membrane Cell, Diaphragm Cell, and Other Production Processes 3) By Application: Pulp and Paper; Organic Chemical; Inorganic Chemical; Soap and Detergent; Alumina; Textile; Other Applications